COR
Cencora, Inc.
-5.97 (-1.87%)312.53USD239K成交股數59.6B市值23.2本益比(近四季)0.2股價營收比+5.1%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 9 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 84.8B+12% | 78.4B-4% | 85.9B+9% | 80.7B+9% | 75.5B+10% | 81.5B+13% | 79.1B+18% | 74.2B+17% | 68.4B | 72.3B | 66.9B | 63.5B |
| 營業成本 | 81.1B | 74.8B | 82.9B | 77.8B | 72.4B | 78.9B | 76.6B | 71.8B | 65.9B | 69.8B | 64.7B | 61.2B |
| 毛利 | 3.6B+18% | 3.6B+40% | 3.1B+23% | 2.9B+21% | 3.1B+21% | 2.6B+4% | 2.5B+10% | 2.4B+5% | 2.5B | 2.5B | 2.3B | 2.3B |
| 毛利率 | 4.3% | 4.6% | 3.6% | 3.6% | 4.1% | 3.1% | 3.2% | 3.2% | 3.7% | 3.4% | 3.4% | 3.6% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 2.1B | 2.0B | 1.8B | 1.7B | 1.6B | 1.5B | 1.5B | 1.4B | 1.4B | 1.4B | 1.3B | 1.3B |
| 營業利益 | 1.1B+8% | 1.1B+62% | 760M+500% | 868M+29% | 1.0B+87% | 706M-14% | 127M-81% | 672M+20% | 553M | 823M | 670M | 561M |
| 營業利益率 | 1.3% | 1.5% | 0.9% | 1.1% | 1.4% | 0.9% | 0.2% | 0.9% | 0.8% | 1.1% | 1.0% | 0.9% |
| 稅後淨利 | 764M+6% | 1.6B+236% | 560M+16448% | 687M+42% | 718M+71% | 489M-19% | 3.4M-99% | 483M+11% | 421M | 602M | 480M | 435M |
| 淨利率 | 0.9% | 2.1% | 0.7% | 0.9% | 1.0% | 0.6% | 0.0% | 0.7% | 0.6% | 0.8% | 0.7% | 0.7% |
| 稀釋 EPS | 3.94+7% | 8.40+236% | 2.87+7075% | 3.52+45% | 3.68+76% | 2.50-16% | 0.04-98% | 2.42+14% | 2.09 | 2.98 | 2.35 | 2.13 |
| 稀釋股數 | 194M | 195M | 195M | 195M | 195M | 195M | 200M | 200M | 201M | 202M | 204M | 204M |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 2.8B | 2.2B | 1.8B | 2.2B | 2.0B | 3.2B | 3.1B | 3.3B | 2.1B | 2.9B | 1.4B | 1.5B |
| 應收帳款 | 25.4B | 24.9B | 26.0B | 24.6B | 23.7B | 24.5B | 23.9B | 24.1B | 22.6B | 21.6B | 20.8B | 19.5B |
| 存貨 | 21.0B | 20.0B | 24.1B | 20.1B | 19.0B | 20.5B | 19.0B | 18.3B | 17.6B | 18.7B | 16.9B | 17.0B |
| 總資產 | 83.8B | 81.7B | 78.4B | 74.0B | 71.2B | 69.1B | 67.1B | 66.8B | 63.9B | 64.7B | 61.2B | 58.8B |
| 有息負債 | 11.4B | 12.2B | 7.6B | 8.0B | 7.1B | 5.9B | 3.8B | 4.2B | 4.2B | 4.2B | 4.2B | 4.7B |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 3.1B | 3.4B | 1.9B | 2.0B | 1.0B | 227M | 646M | 925M | 1.1B | 912M | 686M | 282M |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | −8.6B | −10.0B | −5.8B | −5.8B | −5.1B | −2.7B | −679M | −860M | −2.1B | −1.3B | −2.8B | −3.1B |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | −2.3B | – | – | −2.7B-407% | – | – | – | 885M | – | – |
| 資本支出 | – | – | 119M | – | – | 106M | – | – | – | 74.2M | – | – |
| 自由現金流 | – | – | −2.4B | – | – | −2.8B-448% | – | – | – | 811M | – | – |
| 折舊攤銷 | 269M | 249M | 260M | 254M | 260M | 278M | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | 385M | – | – | – | 386M | – | – |
| 現金股利 | – | – | 127M | – | – | 111M | – | – | – | 106M | – | – |
| 自由現金流率 | – | – | -2.8% | – | – | -3.5% | – | – | – | 1.1% | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 313B
| US Healthcare Solutions | 285B | 91.0% | +9.8% |
|---|---|---|---|
| International Healthcare Solutions | 28.3B | 9.0% | +6.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 321B | +9.3% | 1.6B | 0.5% | 7.96 | 3.2B |
| FY2024 | 294B | +12.1% | 1.5B | 0.5% | 7.53 | 3.0B |
| FY2023 | 262B | +9.9% | 1.7B | 0.7% | 8.53 | 3.5B |
| FY2022 | 239B | +11.5% | 1.7B | 0.7% | 8.04 | 2.2B |
| FY2021 | 214B | +12.7% | 1.5B | 0.7% | 7.39 | 2.2B |
| FY2020 | 190B | +5.7% | −3.4B | -1.8% | -16.65 | 1.8B |
| FY2019 | 180B | +6.9% | 855M | 0.5% | 4.04 | 2.0B |
| FY2018 | 168B | – | 1.7B | 1.0% | 7.53 | 1.1B |